Sangamo raises $200M in follow-on

Sangamo Therapeutics Inc. (NASDAQ:SGMO) raised $200 million through the sale of 12.3 million shares at $16.25 in a follow-on underwritten by BofA Merrill

Read the full 236 word article

How to gain access

Continue reading with a
two-week free trial.